Showing 1,510 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Injectable & long-acting PrEP

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

Editor's pick
POZ
16 November 2020
Clinical trials

Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry

Editor's pick
FDA
10 November 2020
Pharmaceutical industry

GlaxoSmithKline's HIV PrEP challenge looms as ViiV's long-acting drug tops Gilead's Truvada in women

Editor's pick
FiercePharma
10 November 2020
Injectable & long-acting HIV treatment

ViiV Healthcare receives positive CHMP opinion for long-acting regimen for the treatment of HIV

Editor's pick
ViiV Healthcare press release
16 October 2020
Injectable & long-acting HIV treatment

New once-a-week drug could be part of weekly oral treatment

News
13 October 2020
Treatment simplification strategies

GSK's ViiV, armed with long-term Dovato data, eyes 'tipping point' for 2-drug HIV regimen

Editor's pick
FiercePharma
7 October 2020
Pharmaceutical industry

US: Gilead's Truvada faces Teva generics assault amid Descovy switching campaign

Editor's pick
FiercePharma
4 October 2020
Pharmaceutical industry

First Generic Truvada Now Available in the United States

Editor's pick
POZ
4 October 2020
Pharmaceutical industry

US: PrEP Costs Must Come Down for Uptake to Increase, Study Says

Editor's pick
American Journal of Managed Care
28 September 2020
PrEP policies & guidelines

UnitedHealthcare spurns Gilead's newer PrEP drug Descovy as Truvada generic looms: report

Editor's pick
FiercePharma
17 August 2020
Injectable & long-acting HIV treatment

Doravirine injections were safe and long-lasting, but did not reach therapeutic levels

News
4 August 2020
Government, leadership & policy

MSF applauds South Africa for championing health safeguards at meeting of WTO members

Editor's pick
Reliefweb
4 August 2020
Pharmaceutical industry

Rival drugmakers' joint trial of medicines for COVID includes an experimental HIV drug

Editor's pick
Thomson Reuters Foundation
4 August 2020
Global health initiatives

Covidization of research: what are the risks?

Editor's pick
Nature
3 August 2020
Pharmaceutical industry

Gilead raises 2020 sales forecast to include revenue from COVID-19 drug remdesivir

Editor's pick
Business Today India
31 July 2020
Pharmaceutical industry

U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival

Editor's pick
FiercePharma
15 July 2020
New & experimental HIV treatments

FDA spurns CytoDyn's HIV drug because of missing info

Editor's pick
FierceBiotech
14 July 2020
Access to healthcare

NEW DATA: Treat 95% of people living with HIV for just FOUR WEEKS of global HIV drug sales

Editor's pick
ITPC
13 July 2020
Pharmaceutical industry

GSK's ViiV, touting superior long-acting data, can challenge Gilead in HIV prevention: analyst

Editor's pick
FiercePharma
13 July 2020
New & experimental HIV treatments

Dewpoint Therapeutics Collaborates with Merck to Evaluate Novel Approach for the Treatment of HIV

Editor's pick
Dewpoint press release
13 July 2020
Drug-resistant TB

Governments must scale up better TB treatment as J&J drops crucial drug price

Editor's pick
MSF
6 July 2020
Injectable & long-acting HIV treatment

GSK says it is within weeks of resubmitting HIV injection Cabenuva

Editor's pick
Reuters
3 July 2020
Access to healthcare

High price excludes patients from better treatment for drug-resistant TB

Editor's pick
Devex
29 June 2020
HIV treatment for children & young people

FDA approves dolutegravir formulations to treat infants and young children

Editor's pick
i-Base
18 June 2020